BCL2L11 and cancer: In contrast, the frequencies of BIM deletion polymorphism were quite similar (healthy volunteer, 14%; consecutive cancer cohort, 15%; metastatic cancer cohort, 13%) among the three study groups of women >50 years (Table 1 and Fig 1).